| 100 / 1 |
Val‐9Ala and Ile+58Thrpolymorphism of MnSOD inParkinson's disease
|
|
2017-01-23 |
| 101 / 1 |
Growth suppression of HER2‐overexpressing breast cancer cells by berberine via modulation of the HER2/PI3K/Aktsignaling pathway.
|
|
2017-01-23 |
| 101 / 1 |
Magnolol down‐regulates HER2 gene expression, leading to inhibition of HER2‐mediated metastatic potential in ovariancancer cells.
|
|
2017-01-23 |
| 102 / 1 |
Berberine, an isoquinoline alkaloid, inhibits the metastatic potential of breast cancer cells via Akt pathway modulation.
|
|
2017-01-23 |
| 102 / 1 |
Ganoderma tsugae Extract Inhibits Growth of HER2-Overexpressing Cancer Cells via Modulation of HER2/PI3K/Akt Signaling Pathway.
|
|
2017-01-23 |
| 103 / 1 |
Polymorphic Ala-allele carriers at residue 1170 of HER2 associated with Parkinson's disease
|
|
2015-03-13 |
| 105 / 1 |
Growth-suppressive effect of berberine on endometrial carcinoma cells: Role of mitochondrial and PI3K/Akt pathway
|
|
2017-05-18 |
| 111 / 1 |
Dual down-regulation of EGFR and ErbB2 by berberine contributes to suppression of migration and invasion of human ovarian cancer cells.
|
|
2023-11-29 |